# Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder

> **NCT00563992** · PHASE1 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 98 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lithium
- **DRUG:** Valproic acid

## Key facts

- **NCT ID:** NCT00563992
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2012-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563992, "Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00563992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*